Author Question: The process through which malignant brain tumors directly damage neurons is A) the induction of ... (Read 79 times)

tiara099

  • Hero Member
  • *****
  • Posts: 588
The process through which malignant brain tumors directly damage neurons is
 
  A) the induction of hemorrhage.
  B) excessive release of oxygen radicals.
  C) compression and infiltration.
  D) the induction of seizure activity.
  E) overstimulation of neuron activity.

Question 2

Which of the following cells CANNOT give rise to a brain tumor?
 
  A) meningeal cells
  B) neurons
  C) astrocytes
  D) glial cells
  E) ependymal cells



jojobee318

  • Sr. Member
  • ****
  • Posts: 298
Answer to Question 1

Answer: C
Rationale: The process through which malignant brain tumors directly damage neurons is compression and infiltration.

Answer to Question 2

Answer: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library